|
市場調査レポート
欧州における医薬品開発業務受託機関（CRO）市場
Contract Research Organisation (CRO) Markets in Europe
|
Abstract
Research Overview
This analysis is available through our Drug Discovery Technologies Growth
Partnership Services program. With this program, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
To maximize the potential for growth within a firm's internal and external
environment, Frost & Sullivan consultants can facilitate the creation of
strategic programs that deliver improved market success. Frost & Sullivan's
strengths lie in combining strategic understanding with market expertise and
applying these with absolute commitment to its clients' growth.
Table of Contents
- 1. Executive Summary
- 2. Exchange Rates and Glossary of Terms
- 1. Glossary and Exchange Rates
- 1. Glossary of Terms
- 2. Exchange Rates
- 3. Industry Challenges
- 1. Research Scope and Methodology
- 1. Research Scope and Methodology
- 2. Industry Challenges
- 4. Market Engineering Research of the Contract Research Organisation
Markets in Europe
- 1. Forecasts for Contract Research Organisation Markets in Europe
- 1. Introduction
- 2. Market Overview
- 3. Market Segmentation
- 4. Market Engineering Measurements
- 5. Market Drivers
- a. Greater Financial Benefits Leading to Outsourcing Growth
- b. More Expert Knowledge to Build a Strategic Fit
- c. Greater R&D Productivity to Drive Growth
- d. Continued Globalisation Fuels Demand for CRO Services
- e. Clinical Trials Testing from Low Cost Countries and Large Pools of
Untreated Patients
- f. Reduced R&D Complexity and Opportunities to Focus on Core
Competencies
- 6. Market Restraints
- a. Regulatory Hurdles Pose a Quality Challenge and Discourages
Innovation
- b. Security of Proprietary Knowledge Risks Management of Third-Party
Relationships
- c. Lack of Domain Expertise Limits Opportunities
- d. The Breadth of Offerings and Quality of Service Vary Between CROs
- e. Poor Process Design and Low Tolerance Errors
- 7. Revenue Forecasts
- 8. Competitive Structure
- 5. Work Outsourced to CROs Markets in Europe
- 1. Market Engineering Measurements
- 1. Market Engineering Measurements
- 2. Revenue Forecasts
- 1. Revenue Forecast Analysis
- 6. Work Outsourced to Other Organisations Markets in Europe
- 1. Market Engineering Measurements
- 1. Market Engineering Measurements
- 2. Revenue Forecasts
- 1. Revenue Forecast Analysis
- 7. Market Engineering Strategic Recommendations
- 1. Market Engineering Strategic Recommendations
- 1. Strategic Recommendations
- 8. Portfolio Analysis
- 1. Company Profiles
- 1. Charles River Laboratories International Inc.
- 2. Covance Inc.
- 3. ICON Plc.
- 4. Kendle International Inc.
- 5. MDS Pharma Services.
- 6. Omincare Clinical Research Inc.
- 7. PAREXEL International Corp.
- 8. Pharmaceutical Product Development Inc.
- 9. PharmaNet Inc.
- 10. Quintiles Transnational Corp.
- 9. Decision Support Databases
- 1. Decision Support Databases
- 1. Decision Support Databases
- 10. Database of Key Industry Participants
- 1. Key Industry Participants
- 1. List of Key Industry Participants
|
